Literature DB >> 12444315

Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases.

Ronald van Ree1.   

Abstract

Allergenicity of plant and invertebrate N-glycans has been shown to be caused by the presence of two typical nonmammalian substitutions: an alpha(1,3)-fucose linked to the proximal N-acetylglucosamine and a beta(1,2)-xylose linked to the core mannose. IgE antibodies against these carbohydrate structures are induced upon exposure to pollen or after insect stings, and result in extensive cross-reactivity to plant and invertebrate foods. These cross-reactive IgE antibodies have been shown to possess variable degrees of biological activity, but have never been convincingly shown to induce clinical food allergy. The most likely explanation for this lack of clinical relevance has to be sought in a combination of epitope valency and antibody affinity. In diagnostic tests, these antibodies are at the basis of many false-positive test results for food allergy. Recombinant technologies offer the possibility to produce allergens that do not carry IgE-binding glycans. Whether their absence or presence is of importance for the application of recombinant allergens in immunotherapy is still largely unknown. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444315     DOI: 10.1159/000066770

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  26 in total

Review 1.  Cross-reactivity of pollen allergens.

Authors:  Richard W Weber
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

2.  Carbohydrate epitopes as a cause of cross-reactivity in patients allergic to Hymenoptera venom.

Authors:  Renato Erzen; Peter Korosec; Mira Silar; Ema Music; Mitja Kosnik
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 3.  Component resolved testing for allergic sensitization.

Authors:  Kirsten Skamstrup Hansen; Lars K Poulsen
Journal:  Curr Allergy Asthma Rep       Date:  2010-09       Impact factor: 4.806

4.  Ultrasensitive carbohydrate-peptide SPR imaging microarray for diagnosing IgE mediated peanut allergy.

Authors:  Amit A Joshi; Mark W Peczuh; Challa V Kumar; James F Rusling
Journal:  Analyst       Date:  2014-11-21       Impact factor: 4.616

5.  Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis.

Authors:  Elizabeth A Erwin; Hayley R James; Heather M Gutekunst; John M Russo; Kelly J Kelleher; Thomas A E Platts-Mills
Journal:  Ann Allergy Asthma Immunol       Date:  2010-06       Impact factor: 6.347

6.  An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes.

Authors:  Hans Bakker; Gerard J A Rouwendal; Anton S Karnoup; Dion E A Florack; Geert M Stoopen; Johannes P F G Helsper; Ronald van Ree; Irma van Die; Dirk Bosch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-04       Impact factor: 11.205

7.  Relationship between red meat allergy and sensitization to gelatin and galactose-α-1,3-galactose.

Authors:  Raymond James Mullins; Hayley James; Thomas A E Platts-Mills; Scott Commins
Journal:  J Allergy Clin Immunol       Date:  2012-04-03       Impact factor: 10.793

8.  Ara h 6 complements Ara h 2 as an important marker for IgE reactivity to peanut.

Authors:  Audrey E Koid; Martin D Chapman; Robert G Hamilton; Ronald van Ree; Serge A Versteeg; Stephen C Dreskin; Stef J Koppelman; Sabina Wünschmann
Journal:  J Agric Food Chem       Date:  2013-12-26       Impact factor: 5.279

9.  Exploring the free-energy landscape of carbohydrate-protein complexes: development and validation of scoring functions considering the binding-site topology.

Authors:  Sameh Eid; Noureldin Saleh; Adam Zalewski; Angelo Vedani
Journal:  J Comput Aided Mol Des       Date:  2014-09-10       Impact factor: 3.686

Review 10.  When does a protein become an allergen? Searching for a dynamic definition based on most advanced technology tools.

Authors:  A Mari
Journal:  Clin Exp Allergy       Date:  2008-07       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.